Document is current
Any future updates will be listed below
-
Authors
Zaman, Zakia
Islam, Radia
Koganti, Bhavya
Falki, Vaibhavkumar
Osentoski, Tammy
Graham, Stewart
Sharoar, Md. Golam
-
Funding
Funding for this research was provided by:
This work is supported by the Alzheimer’s disease Research Program startup fund to Dr. Sharoar from the Corewell Health East (formally Beaumont Health).
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 22 October 2024
First Online: 14 November 2024
Declarations
:
: The study was approved by the Human Investigation Committee of Corewell Health East (CHE) (formally William Beaumont Hospital), Royal Oak, MI, USA under an approved protocol by the Institutional Review Board (IRB#2017 − 214). The CHE Institutional Review Board is accredited by the Association for the Accreditation of Human Research Protection Programs and complies with Good Clinical Practice Guidelines as defined by the U.S. Food and Drug Administration under the Code of Federal Regulations (21 CFR Parts 50 and 56; 45 CFR Part 46) and International Conference on Harmonization (ICH) Guidelines (Section E6). Written consent was obtained from study participants or their legal representatives prior to obtaining the data.
: The authors declare no competing interests.
